What is Tend?
Tend operates as a sophisticated telehealth care provider, bridging the gap between traditional medical consultations and digital convenience. The company offers a comprehensive mobile application that enables patients to address common health concerns, manage prescription refills, obtain medical certificates, and secure specialist referrals. By integrating ACC injury support and streamlined clinical workflows, Tend has established itself as a vital player in the health tech sector, focusing on accessibility and efficiency in patient-centric care delivery. Its market position is defined by a commitment to reducing barriers to entry for primary health services through a robust, user-friendly digital interface.
How much funding has Tend raised?
Tend has raised a total of $15M across 1 funding round:
Unspecified
$15M
Unspecified (2021): $15M with participation from Dr. Lee Mathias, Marko Bogoievski, Cecelia Robinson, Theresa Gattung, and James Robinson
Key Investors in Tend
Dr. Lee Mathias
A medical professional and strategic investor with a focus on clinical innovation and healthcare delivery systems.
Marko Bogoievski
An experienced executive and investor known for supporting high-growth infrastructure and service-oriented enterprises.
Cecelia Robinson
A prominent investor and business leader with a track record of backing scalable digital platforms and consumer-facing technologies.
What's next for Tend?
With the infusion of this major strategic investment, Tend is expected to prioritize the scaling of its technological infrastructure and the expansion of its clinical service offerings. The company is likely to focus on enhancing its diagnostic capabilities and deepening its integration with existing healthcare ecosystems to provide a more seamless patient experience. As the telehealth sector continues to undergo rapid digital transformation, Tend's ability to maintain high standards of care while scaling its user base will be the primary metric for its long-term viability. Future growth strategies will likely involve optimizing patient acquisition costs and diversifying its service portfolio to include more complex chronic disease management tools, thereby solidifying its role as a leader in the evolving virtual medicine market.
See full Tend company page
